SIRT3 overexpressed in chronic lymphocytic leukemia (CLL) (Maiti et al., 2021) and diffuse large B cell lymphomas (DLBCLs) (Li et al., 2019) cells contributes to the proliferation, survival and self-renewal of tumor cells. Here, SIRT3 is linked to B-cell chronic lymphocytic leukemia.